Deep cervical lymphaticovenous anastomosis is a procedure that connects lymphatic vessels to veins. This review looked at whether this surgery could help patients with Alzheimer's disease. The authors found that we simply do not know enough about how this procedure works inside the body. There are big gaps in our understanding of the underlying physiology. Scientists have not yet solved key questions about pressure gradients or how the lymphatic system contracts. They also do not know the risk of fluid leaking back or if the connection stays open long enough to help. We also lack proof that specific blood markers can validate the procedure's success. Because of these unresolved scientific questions, a regulatory body has suspended the clinical use of this surgery for Alzheimer's. Until these gaps are addressed, widespread application cannot be justified. The potential benefits remain theoretical at this stage. Patients and doctors must wait for more solid evidence before considering this option.
Regulatory suspension blocks use of DCLVA for Alzheimer's disease
Photo by MARIOLA GROBELSKA / Unsplash
What this means for you:
Regulatory suspension blocks use of DCLVA for Alzheimer's disease until scientific gaps are filled. More on Alzheimer's Disease
Ceramides emerge as key players in Alzheimer's pathology but therapeutic targeting faces hurdles Ceramides may help Alzheimer's but brain barriers and safety remain unclear
Frontiers · Jun 5, 2026
Obesity in older adults lowers Alzheimer's risk while underweight status and weight loss increase it Obesity protects older adults from Alzheimer's risk, but not younger ones
· Jun 5, 2026
GLP-1 receptor agonists may reduce cognitive decline in type 2 diabetes patients with dementia GLP-1 drugs may slow cognitive decline in type 2 diabetes
· Jun 5, 2026
Meta-analysis identifies 311 serum metabolite associations in Alzheimer's disease trajectory New blood tests reveal how Alzheimer's changes your body over seven years
medRxiv · Jun 4, 2026